Protagenic Therapeutics, Inc. (OTCMKTS:PTIX) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $2.95 and traded as high as $6.25. Protagenic Therapeutics shares last traded at $5.20, with a volume of 2,396 shares changing hands.
The company has a market cap of $54.71 million, a P/E ratio of -27.37 and a beta of -4.05. The company has a fifty day moving average price of $6.00 and a two-hundred day moving average price of $2.97.
Protagenic Therapeutics Company Profile (OTCMKTS:PTIX)
Protagenic Therapeutics, Inc engages in the discovery and development of therapeutics to treat central nervous system disorders. Its lead drug candidate is PT00114, which is in clinical proof-of-concept studies for the treatment-resistant depression and/or post-traumatic stress disorder. The company is based in New York, New York.
See Also: Why do companies engage in swaps?
Receive News & Ratings for Protagenic Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Protagenic Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.